Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Henriette Kyepa
Observed names:
H Kyepa,
H. Kyepa
Observed institutions:
Institut Pasteur,
Université Paris Cité,
Assistance Publique – Hôpitaux de Paris,
Hôpital Saint-Louis
OpenAlex ID:
A5009002968
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial
2022
·
David S Lawrence
, Charles Muthoga
, et al.
·
The Lancet Global Health
·
33
PDF
Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study
2024
·
Tshepiso Mbangiwa
, Aude Sturny-Leclère
, et al.
·
The Lancet Microbe
·
16
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Show more works
View as search
Works count:
7
Citation count:
236
H-index:
5
I10-index:
5
Year
Topic
Type